invirase
Invirase (Saquinavir Mesylate) is a medication used to treat Acquired Immunodeficiency Syndrome.
Saquinavir Mesylate · by Hoffmann La Roche
Key facts
- Active ingredient
- Saquinavir Mesylate
- Form
- Tablet, Capsule
- Strength
- Saquinavir Mesylate EQ 200MG Base
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- acquired immunodeficiency syndrome
- Manufacturer
- Hoffmann La Roche
- FDA application
- NDA020628
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Tablet and Capsule
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Invirase treat?
- Invirase (Saquinavir Mesylate) may be used to treat acquired immunodeficiency syndrome, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Invirase?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Invirase. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Invirase?
- Invirase is marketed by Hoffmann La Roche. You can see Hoffmann La Roche's full profile, rating, and other products on pharmaranks.
- Is Invirase a brand-name or generic drug?
- Invirase is a brand-name product with the active ingredient Saquinavir Mesylate.
- Is Invirase available over the counter?
- No. Invirase is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Invirase come in?
- Invirase is currently marketed as tablet and capsule, per the FDA's National Drug Code Directory.
- Is Invirase FDA-registered?
- Invirase is on record with the U.S. FDA under application number NDA020628. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about SAQUINAVIR MESYLATE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 1,660 reports naming SAQUINAVIR MESYLATE — the active ingredient in Invirase, and the FDA flagged 97% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- lipodystrophy acquired244 reports
- mitochondrial toxicity201 reports
- eyelid ptosis198 reports
- diplopia194 reports
- drug resistance121 reports
- dysphagia114 reports
- viral mutation identified105 reports
- progressive external ophthalmoplegia98 reports
Read these as a signal, not a rate. A report does not mean SAQUINAVIR MESYLATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
aptivus
Tipranavir
reyataz
Atazanavir Sulfate
vemlidy
Tenofovir Alafenamide Fumarate
viread
Tenofovir Disoproxil Fumarate
lamivudine
Lamivudine
nevirapine
Nevirapine
Compare Invirase head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
invirase
New